What is Ipamorelin?

An introduction to ipamorelin, a selective growth hormone secretagogue that was never approved.

Last updated: January 19, 2026

What is Ipamorelin?

Ipamorelin is a synthetic peptide that stimulates the body to release growth hormone. It was developed to be more selective than earlier GH-releasing peptides.

Key Facts

FactDetail
FDA ApprovedNo
Development StatusDiscontinued
WADA StatusProhibited

How Does It Claim to Work?

Ipamorelin binds to ghrelin receptors and stimulates growth hormone release from the pituitary gland. Unlike older peptides, it has minimal effects on cortisol and prolactin.

Why Isn’t It Approved?

Pharmaceutical development was discontinued. While some human studies were done, the development program was not completed, and no application for approval was submitted.

Selectivity Advantage

EffectGHRP-6Ipamorelin
GH ReleaseYesYes
CortisolIncreasesMinimal
ProlactinIncreasesMinimal
AppetiteStrongLess

Important Warnings

  • Not approved for any medical use
  • Available only through unregulated sources
  • Long-term safety unknown
  • Banned in competitive sports

This guide is for educational purposes only. Ipamorelin is not approved by regulatory agencies.

Related Content

Get Research Alerts

New dossiers and major study summaries delivered to your inbox. No spam, just evidence.

No spam. Unsubscribe anytime.

Disclaimer: This educational guide does not constitute medical advice. The information presented is based on current research but should not be used for diagnosis, treatment, or prevention of any disease. Always consult a qualified healthcare provider before making health decisions.